Evidence map›Paper›PMID 21910479›Full record

ArticleChemical research in toxicology2011

Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.

Carol A Shultz, Amy M Quinn, Jong-Heum Park, Ronald G Harvey, Judy L Bolton, Edmund Maser, Trevor M Penning

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genotoxicity ofToxicology research · 2017
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carol A ShultzDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Amy M Quinn
Jong-Heum Park
Ronald G Harvey
Judy L Bolton
Edmund Maser
Trevor M Penning
University of Pennsylvania · USMay Institute · USUniversity of Illinois Chicago · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3M
Regulation of protein kinase C and cell cycle by PAH o-quinones and ROSP01CA092537 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PENNING, TREVOR M. · 2002 to 2006
$7.3M
DIHYDRODIOL DEHYDROGENASE AND THE ASPIRIN-LIKE DRUGSR01CA039504 · NCI · UNIVERSITY OF PENNSYLVANIA · PI PENNING, TREVOR M · 1986 to 2014
$3.8M
NCI NIH HHS P01 CA092537NCI NIH HHS P01-CA92537,NCI NIH HHS R01 CA039504NCI NIH HHS R01-CA39504NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P30-ES 013508PHS HHS PA-DOH4100038714
6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are suspect human lung carcinogens and can be metabolically activated to remote quinones, for example, benzo[a]pyrene-1,6-dione (B[a]P-1,6-dione) and B[a]P-3,6-dione by the action of either P450 monooxygenase or peroxidases, and to non-K region o-quinones, for example B[a]P-7,8-dione, by the action of aldo keto reductases (AKRs). B[a]P-7,8-dione also structurally resembles 4-hydroxyequilenin o-quinone. These three classes of quinones can redox cycle, generate reactive oxygen species (ROS), and produce the mutagenic lesion 8-oxo-dGuo and may contribute to PAH- and estrogen-induced carcinogenesis. We compared the ability of a complete panel of human recombinant AKRs to catalyze the reduction of PAH o-quinones in the phenanthrene, chrysene, pyrene, and anthracene series. The specific activities for NADPH-dependent quinone reduction were often 100-1000 times greater than the ability of the same AKR isoform to oxidize the cognate PAH-trans-dihydrodiol. However, the AKR with the highest quinone reductase activity for a particular PAH o-quinone was not always identical to the AKR isoform with the highest dihydrodiol dehydrogenase activity for the respective PAH-trans-dihydrodiol. Discrete AKRs also catalyzed the reduction of B[a]P-1,6-dione, B[a]P-3,6-dione, and 4-hydroxyequilenin o-quinone. Concurrent measurements of oxygen consumption, superoxide anion, and hydrogen peroxide formation established that ROS were produced as a result of the redox cycling. When compared with human recombinant NAD(P)H:quinone oxidoreductase (NQO1) and carbonyl reductases (CBR1 and CBR3), NQO1 was a superior catalyst of these reactions followed by AKRs and last CBR1 and CBR3. In A549 cells, two-electron reduction of PAH o-quinones causes intracellular ROS formation. ROS formation was unaffected by the addition of dicumarol, suggesting that NQO1 is not responsible for the two-electron reduction observed and does not offer protection against ROS formation from PAH o-quinones.

Indexed as

Alcohol OxidoreductasesAldehyde ReductaseAldo-Keto ReductasesBenzopyrenesBiocatalysisCell Line, TumorEquileninHumansIsomerismNAD(P)H Dehydrogenase (Quinone)Oxidation-ReductionPolycyclic Aromatic HydrocarbonsQuinonesReactive Oxygen SpeciesRecombinant ProteinsSubstrate Specificity4-hydroxyequilenin-o-quinoneAlcohol OxidoreductasesAldehyde ReductaseAldo-Keto Reductasesbenzo(a)pyrene-7,8-dioneBenzopyrenesEquileninNAD(P)H Dehydrogenase (Quinone)Polycyclic Aromatic HydrocarbonsQuinonesReactive Oxygen SpeciesRecombinant Proteins

Identifiers

PMID21910479
PMCPMC3251162
OpenAlexW2066120997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.